Medical College of Acu-Moxi and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou, China.
Guangzhou Health Science College, Guangzhou, China.
Medicine (Baltimore). 2021 Nov 19;100(46):e27686. doi: 10.1097/MD.0000000000027686.
Patients with amnesic mild cognitive impairment (aMCI) are more likely to develop Alzheimer disease than corresponding age normal population. Because Alzheimer disease is irreversible, early intervention for aMCI patients seems important and urgent. We have designed a pilot multicenter, randomized, parallel controlled trial to assess the efficacy and safety of acupuncture on aMCI, explore the feasibility of acupuncture in the treatment of aMCI, so as to provide a reference for large-sample clinical trials in the next stage.
We designed a pilot multicenter, randomized, parallel controlled trial. This trial aims to test the feasibility of carrying out a large-sample clinical trial. In this trial, 50 eligible patients with aMCI will be included and allocated to acupuncture group (n = 25) or sham acupuncture group (n = 25) at random. Subjects will accept treatment 2 times a week for 12 weeks continuously, with a total of 24 treatment sessions. We will select 6 acupoints (GV20, GV14, bilateral BL18, bilateral BL23). For the clinical outcomes, the primary outcome is Montreal cognitive assessment, which will be assessed from baseline to the end of this trial. And the secondary outcomes are Mini-mental State Examination, Delayed Story Recall, Clinical Dementia Rating scale, Global Deterioration Scale, Activity of Daily Life, Alzheimer Disease Assessment Scale-Cognitive Section, brain magnetic resonance imaging, brain functional magnetic resonance imaging, and event-related potential P300, which will be assessed before and after treatment. In addition, we will assess the safety outcomes from baseline to the end of this trial and feasibility outcome after treatment. We will evaluate neuropsychological assessment scale (Montreal cognitive assessment, Mini-mental State Examination, Alzheimer Disease Assessment Scale-Cognitive Section) at 3 months and 6 months after treatment.
This pilot trial aims to explore the feasibility of the trial, verify essential information of its efficacy and safety. This pilot study will provide a preliminary basis for carrying out a larger clinical trial of acupuncture on aMCI in near future.
遗忘型轻度认知障碍(aMCI)患者比相应年龄的正常人群更有可能发展为阿尔茨海默病。由于阿尔茨海默病是不可逆转的,因此对 aMCI 患者进行早期干预似乎很重要且紧迫。我们设计了一项多中心、随机、平行对照的临床试验,以评估针刺治疗 aMCI 的疗效和安全性,探索针刺治疗 aMCI 的可行性,为下一阶段的大样本临床试验提供参考。
我们设计了一项多中心、随机、平行对照的临床试验。该试验旨在测试开展大样本临床试验的可行性。在该试验中,将纳入 50 名符合条件的 aMCI 患者,随机分为针刺组(n=25)或假针刺组(n=25)。受试者将每周接受 2 次治疗,连续 12 周,共 24 次治疗。我们将选择 6 个穴位(GV20、GV14、双侧 BL18、双侧 BL23)。对于临床结局,主要结局是蒙特利尔认知评估,将从基线评估到试验结束。次要结局包括简易精神状态检查、延迟故事回忆、临床痴呆评定量表、总体衰退量表、日常生活活动、阿尔茨海默病评估量表认知部分、脑磁共振成像、脑功能磁共振成像和事件相关电位 P300,这些将在治疗前后进行评估。此外,我们将在试验结束时评估安全性结局和治疗后的可行性结局。我们将在治疗后 3 个月和 6 个月评估神经心理评估量表(蒙特利尔认知评估、简易精神状态检查、阿尔茨海默病评估量表认知部分)。
本试验旨在探索该试验的可行性,验证其疗效和安全性的基本信息。本研究将为今后开展更大规模的针刺治疗 aMCI 的临床试验提供初步依据。